Stabilized formulations containing anti-ngf antibodies

PK201100527A0Undetermined Publication Date: 2011-08-03REGENERON PHARMACEUTICALS INC

0 Cites 0 Cited by

Patent Information

Authority / Receiving Office: PK · PK
Patent Type: Applications
Current Assignee / Owner: REGENERON PHARMACEUTICALS INC
Filing Date: 2011-07-11
Publication Date: 2011-08-03

Application Information

Patent Timeline

11 Jul 2011

Application

03 Aug 2011

Publication

PK201100527A0

AI Tagging

Technology Topics

Antiendomysial antibodies Biochemistry

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗

Similar Technology Patents

Get free access to AI patent search and analysis

Check patentability, review prior art and ask IP Agent with full patent context.

Patent Text Reader

Abstract

The present invention provides a pharmaceutical formulation comprising a human antibody that specifically binds to human nerve growth factor (hNGF). The formulation may contain, in addition to an anti-hNGF antibody, at least one non-ionic surfactant, at least one sugar, and acetate. The pharmaceutical formulation of the present invention exhibits a substantial degree of antibody stability after storage for several months.

Need to check novelty before this filing date? Find Prior Art